Last updated: 3 months ago
Mineralys Therapeutics Q1 2023 Financial Report: Promising Yet Cautionary Insights
Explore Mineralys Therapeutics' Q1 2023 financial report, highlighting IPO success, ongoing losses, and a 'Hold' investment recommendation amidst strong R&D focus.